TAIDOC TECHNOLOGY CORP - Asset Resilience Ratio
TAIDOC TECHNOLOGY CORP (4736) has an Asset Resilience Ratio of 23.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See financial agility of TAIDOC TECHNOLOGY CORP to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how TAIDOC TECHNOLOGY CORP's Asset Resilience Ratio has changed over time. See net asset quality index of TAIDOC TECHNOLOGY CORP to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down TAIDOC TECHNOLOGY CORP's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4736 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$3.01 Billion | 23.03% |
| Total Liquid Assets | NT$3.01 Billion | 23.03% |
Asset Resilience Insights
- Good Liquidity Position: TAIDOC TECHNOLOGY CORP maintains a healthy 23.03% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
TAIDOC TECHNOLOGY CORP Industry Peers by Asset Resilience Ratio
Compare TAIDOC TECHNOLOGY CORP's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual Asset Resilience Ratio data for TAIDOC TECHNOLOGY CORP.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 24.68% | NT$3.16 Billion ≈ $99.41 Million |
NT$12.78 Billion ≈ $402.78 Million |
+3.80pp |
| 2024-09-30 | 20.88% | NT$2.56 Billion ≈ $80.51 Million |
NT$12.24 Billion ≈ $385.62 Million |
+11.31pp |
| 2023-09-30 | 9.57% | NT$1.14 Billion ≈ $35.89 Million |
NT$11.91 Billion ≈ $375.08 Million |
-0.51pp |
| 2022-09-30 | 10.07% | NT$1.30 Billion ≈ $40.95 Million |
NT$12.90 Billion ≈ $406.49 Million |
+7.79pp |
| 2021-09-30 | 2.29% | NT$240.87 Million ≈ $7.59 Million |
NT$10.52 Billion ≈ $331.52 Million |
+1.55pp |
| 2020-09-30 | 0.73% | NT$67.38 Million ≈ $2.12 Million |
NT$9.17 Billion ≈ $288.87 Million |
+0.15pp |
| 2019-09-30 | 0.59% | NT$46.06 Million ≈ $1.45 Million |
NT$7.83 Billion ≈ $246.61 Million |
-0.31pp |
| 2018-09-30 | 0.90% | NT$67.53 Million ≈ $2.13 Million |
NT$7.53 Billion ≈ $237.37 Million |
+0.04pp |
| 2017-09-30 | 0.85% | NT$51.68 Million ≈ $1.63 Million |
NT$6.06 Billion ≈ $191.07 Million |
0.00pp |
| 2016-09-30 | 0.86% | NT$43.39 Million ≈ $1.37 Million |
NT$5.07 Billion ≈ $159.65 Million |
-0.10pp |
| 2015-09-30 | 0.96% | NT$41.53 Million ≈ $1.31 Million |
NT$4.34 Billion ≈ $136.66 Million |
+0.93pp |
| 2014-09-30 | 0.02% | NT$907.00K ≈ $28.58K |
NT$3.96 Billion ≈ $124.72 Million |
+0.02pp |
| 2013-09-30 | 0.01% | NT$179.00K ≈ $5.64K |
NT$3.19 Billion ≈ $100.52 Million |
-0.31pp |
| 2010-09-30 | 0.32% | NT$9.73 Million ≈ $306.49K |
NT$3.07 Billion ≈ $96.81 Million |
-0.13pp |
| 2009-09-30 | 0.44% | NT$11.83 Million ≈ $372.62K |
NT$2.66 Billion ≈ $83.84 Million |
-- |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more